Cancer clinical trials in the region Grand Est
272 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Liver and bile duct cancer
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Locally Advanced
Metastatic
HER2
1
2
3 or more
Chemotherapy
Systemic Treatment-Naive
1 recruiting site
Jazz Pharmaceuticals
Early Access
Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer
Urothelial carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC
Early Access
Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer
Urothelial carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
1 recruiting site
Astellas Pharma Développement mondial, Inc.
Early Access
Kidney cancer
Pancreas cancer
Clear cell carcinoma
Neuroendocrine tumor
Localized
Von Hippel-Lindau syndrome (VHL)
1 recruiting site
Merck Sharp & Dohme LLC
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Janssen
Phase 3
Prostate cancer
#NCT06136650
#2023-504957-11-00
Adenocarcinoma
Metastatic Castration-resistant
Hormone therapy
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Lymphoma
#NCT06284122
#2023-505436-35-00
B cell lymphoma
Follicular lymphoma
30-50 ml/min
< 30 ml/min
None
Systemic Treatment-Naive
Allogeneic stem cell transplant
Radiotherapy
37 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3
Kidney cancer
#NCT07227402
#2024-517136-21-00
Clear cell carcinoma
Locally Advanced
Metastatic
None
Immunotherapy
Systemic Treatment-Naive
11 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT07318558
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Serous high grade carcinoma (HGSOC)
Localized
HRD Negative
None
Surgery
Chemotherapy
5 recruiting sites
Merck Sharp & Dohme LLC